Juno Therapeutics (JUNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 232,781 | 449,837 | 218,694 | 205,704 | 187,891 |
| Marketable Securities | 493,344 | 477,697 | 478,927 | 516,476 | 544,684 |
| Receivables | 13,912 | 34,335 | 10,350 | 8,824 | 13,286 |
| TOTAL | $753,354 | $972,457 | $736,645 | $779,524 | $772,332 |
| Non-Current Assets | |||||
| PPE Net | 133,110 | 131,623 | 124,341 | 102,517 | 81,734 |
| Investments And Advances | 247,735 | 128,195 | 104,156 | 128,472 | 189,706 |
| Intangibles | 296,563 | 298,468 | 299,680 | 299,806 | 299,292 |
| Other Non-Current Assets | 4,074 | 3,748 | 4,143 | 4,345 | 6,400 |
| TOTAL | $681,482 | $562,034 | $532,320 | $535,140 | $577,132 |
| Total Assets | $1,434,836 | $1,534,491 | $1,268,965 | $1,314,664 | $1,349,464 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,416 | 8,318 | 5,061 | 3,206 | 4,415 |
| Accrued Expenses | 81,244 | 80,870 | 55,974 | 45,357 | 36,822 |
| Other current liabilities | 93,763 | 86,769 | 49,411 | 32,217 | 30,391 |
| TOTAL | $208,752 | $203,904 | $144,907 | $122,598 | $114,892 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,945 | 10,010 | 10,074 | N/A | N/A |
| Deferred Revenues | 21,329 | 27,947 | 34,461 | 41,818 | 43,264 |
| Other Non-Current Liabilities | 22,656 | 66,621 | 65,336 | 60,129 | 13,291 |
| TOTAL | $179,102 | $182,814 | $186,873 | $176,014 | $156,871 |
| Total Liabilities | $387,854 | $386,718 | $331,780 | $298,612 | $271,763 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 116,105 | 114,173 | 106,319 | 106,101 | 106,020 |
| Common Shares | 12 | 12 | 11 | 11 | 11 |
| Retained earnings | -1,268,343 | -1,132,307 | -1,014,174 | -913,434 | -831,237 |
| Other shareholders' equity | 3,421 | 2,504 | 630 | -663 | -2,842 |
| TOTAL | $1,046,982 | $1,147,773 | $937,185 | $1,016,052 | $1,077,701 |
| Total Liabilities And Equity | $1,434,836 | $1,534,491 | $1,268,965 | $1,314,664 | $1,349,464 |